Sarepta Therapeutics Inc [NASDAQ: SRPT] closed the trading session at $21.97 on 2025-07-17. The day’s price range saw the stock hit a low of $20.94, while the highest price level was $22.86.
The stocks have a year to date performance of -85.61 percent and weekly performance of 15.24 percent. The stock has been moved at -81.51 percent over the last six months. The stock has performed 4.92 percent around the most recent 30 days and changed -59.63 percent over the most recent 3-months.
If compared to the average trading volume of 5.62M shares, SRPT reached to a volume of 19630116 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sarepta Therapeutics Inc [SRPT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SRPT shares is $48.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SRPT stock is a recommendation set at 2.11. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Sarepta Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on June 20, 2025. The new note on the price target was released on June 18, 2025, representing the official price target for Sarepta Therapeutics Inc stock.
The Price to Book ratio for the last quarter was 1.89, with the Price to Cash per share for the same quarter was set at 5.32.
SRPT stock trade performance evaluation
Sarepta Therapeutics Inc [SRPT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.24. With this latest performance, SRPT shares gained by 4.92% in over the last four-week period, additionally sinking by -81.51% over the last 6 months – not to mention a drop of -81.93% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SRPT stock in for the last two-week period is set at 45.87, with the RSI for the last a single of trading hit 1.79, and the three-weeks RSI is set at 2.21 for Sarepta Therapeutics Inc [SRPT]. The present Moving Average for the last 50 days of trading for this stock 29.72, while it was recorded at 19.19 for the last single week of trading, and 86.39 for the last 200 days.
Sarepta Therapeutics Inc [SRPT]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Sarepta Therapeutics Inc [SRPT] shares currently have an operating margin of -5.25% and a Gross Margin at 80.07%. Sarepta Therapeutics Inc’s Net Margin is presently recorded at -11.12%.
Sarepta Therapeutics Inc (SRPT) Capital Structure & Debt Analysis
According to recent financial data for Sarepta Therapeutics Inc. ( SRPT), the Return on Equity (ROE) stands at -23.61%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -7.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Sarepta Therapeutics Inc’s Return on Invested Capital (ROIC) is -9.99%, showcasing its effectiveness in deploying capital for earnings.
Sarepta Therapeutics Inc (SRPT) Efficiency & Liquidity Metrics
Based on Sarepta Therapeutics Inc’s (SRPT) latest financial statements, the Debt-to-Equity Ratio is 1.18%, indicating its reliance on debt financing relative to shareholder equity.
Sarepta Therapeutics Inc (SRPT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Sarepta Therapeutics Inc. (SRPT) effectively leverages its workforce, generating an average of -$181042.27 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.02% and a Quick Ratio of 2.46%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Sarepta Therapeutics Inc [SRPT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SRPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sarepta Therapeutics Inc go to 10.81%.
Sarepta Therapeutics Inc [SRPT]: Institutional Ownership
There are presently around $96.33%, or 100.78% of SRPT stock, in the hands of institutional investors. The top three institutional holders of SRPT stocks are: BLACKROCK INC. with ownership of 10.32 million shares, which is approximately 10.9117%. VANGUARD GROUP INC, holding 9.04 million shares of the stock with an approximate value of $$1.43 billion in SRPT stocks shares; and VANGUARD GROUP INC, currently with $$682.69 million in SRPT stock with ownership which is approximately 4.5666%.
